Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 60 and up

Can short-term atorvastatin around surgery help prevent atrial fibrillation after lung surgery?

Official title: Perioperative Statin Therapy for the Prevention of Atrial Fibrillation After Anatomical Lung Resection: A Randomized Controlled Trial

Run by Peking Union Medical College Hospital · NCT07727681 · Data updated 2026-11-12

This trial tests whether giving a short course of atorvastatin around surgery can reduce new atrial fibrillation after lung resection in adults aged 60 and older.

Quick facts

PhasePhase 4
Study typeInterventional
Ages60 Years and up
SexAll
Enrollment540 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations2 sites (Beijing and 1 other locations)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedSeptember 1, 2027
Study endsJanuary 2, 2028
Registry record updatedJuly 28, 2026
Trial IDNCT07727681 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 60 years or older scheduled for isolated lung resection (segmentectomy or lobectomy) with sinus rhythm and not on antiarrhythmic therapy (except beta-blockers).

Probably not a fit

Patients with certain liver, kidney, or muscle conditions, or those with a statin allergy or recent medications that interact with statins, may not benefit and could be excluded for safety.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, phase 4 trial compares short-term atorvastatin to a matching placebo in adults 60 and older undergoing isolated lung resection. Participants are assigned to receive atorvastatin or placebo around the time of surgery to see if it lowers the rate of atrial fibrillation or related rapid heart rhythms within 72 hours post-surgery. The study also monitors safety by tracking liver, kidney, and muscle-related laboratory changes during treatment. Standard postoperative care is provided to all participants, with outcomes assessed through rhythm monitoring and lab tests. The trial is conducted at Peking Union Medical College Hospital in Beijing, with everyone following the same protocol.

Why it matters

Potential benefit: If successful, perioperative atorvastatin could reduce the risk of postoperative atrial fibrillation and related complications.

How similar studies have gone: Prior research suggests statins may have antiarrhythmic benefits in perioperative settings, but this specific perioperative statin approach for lung surgery is being evaluated for efficacy and safety.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 60 years or older.
* Scheduled to undergo isolated anatomical lung resection, including pulmonary segmentectomy or lobectomy.
* Sinus rhythm documented by a preoperative electrocardiogram.
* Not receiving antiarrhythmic medication, with the exception of beta-blockers.
* Willing and able to provide written informed consent.

Exclusion Criteria:

* Untreated hyperthyroidism or hypothyroidism.
* History of obstructive hepatobiliary disease, active liver disease, or other serious liver disease.
* Preoperative serum creatinine greater than 150 μmol/L.
* Known allergy to atorvastatin or another statin, or a history of a serious statin-related adverse reaction, including statin-associated myopathy.
* Personal or family history of an inherited muscle disorder.
* Continuous use within 1 month before randomization of fibrates, niacin, or medications that strongly inhibit cytochrome P450 or P-glycoprotein, including cyclosporine, oral azole antifungal agents, certain interacting antibiotics, protease inhibitors, nefazodone, or amiodarone.
* Consumption of 1 liter or more of grapefruit juice per day within 1 month before randomization.
* Current treatment with a high-intensity statin regimen, including atorvastatin 40 mg/day or higher or rosuvastatin 20 mg/day or higher.
* Any other condition that, in the investigator's judgment, would make participation unsafe or interfere with the conduct or evaluation of the study.

Where it's running

  • Peking Union Medical College Hospital
    Beijing, China
    Recruiting
  • Peking Union Medical College Hospital
    Beijing, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.